首页 | 本学科首页   官方微博 | 高级检索  
检索        

非离子表面活性剂逆转肿瘤细胞多药耐药性的机制
引用本文:武建毅,刘岽,唐亮,谈立松.非离子表面活性剂逆转肿瘤细胞多药耐药性的机制[J].实用医药杂志(山东),2007,24(1):87-88,91.
作者姓名:武建毅  刘岽  唐亮  谈立松
作者单位:上海市肺科医院免疫治疗科 上海200433
摘    要:目的探讨非离子表面活性剂聚氧乙烯醚﹑聚乙二醇300﹑曲拉通X100对肺癌耐药细胞A549/DDP(耐顺铂)多药耐药性的逆转及其机制。方法用四氮唑盐(MTT)法进行体外耐药逆转实验,Westernblot检测P-gp(P-糖蛋白)蛋白的表达。结果①合用非离子型表活剂前后,A549/DDP对化疗药物阿霉素、顺铂、丝裂霉素、5-氟尿嘧啶、依托泊甙和长春新碱的敏感性显著增加(各组都为P<0.01);②三种非离子型表面活性剂能抑制P-gp蛋白的表达。结论三种非离子表面活性剂具有逆转A549/DDP耐药性的作用,逆转机制与其抑制P-gp蛋白的表达有关。

关 键 词:表面活性剂  肺癌  A549/DDP  多药耐药  P-gp
收稿时间:2006-08-03
修稿时间:2006-08-03

Study on the reversal of cancer cell's multidrug resistance by non-ionic surfactant and its mechanism
WU Jian-yi, LIU Dong, TANG Liang,et al..Study on the reversal of cancer cell''''s multidrug resistance by non-ionic surfactant and its mechanism[J].Practical Journal of Medicine & Pharmacy,2007,24(1):87-88,91.
Authors:WU Jian-yi  LIU Dong  TANG Liang  
Institution:the Central Laboratory
Abstract:Objective To discuss whether the non-ionic surfactant (CremophorEL, PEG300, TritonX-100)can reverse the miltidrug resistance(MDR) of the lung cancer cell strian A549/DDP or not and their mechanism. Methods The reversing drug resistance was studied by MTT, expression of P-gp was detected by Western blot.Results (1)MTT cytotoxic assay revealed that the sensitivities of A549/DDP cells to chemotherapy drugs were significant changed according to presence or absence of non-ionic surfactant(P<0.01); (2)The three non-ionic surfactant can inhibit expression of p-gp.Conclusion The three non-ionic surfactant can reverse the MDR of the lung cancer cell strian A549/DDP,inhibiting expression of p-gp maybe its mechanism.
Keywords:A549/DDP  P-gp
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号